Mark Wilterding, Chief Financial Officer at RxSight, sold RXST on Sep 2, 2026

Data as of Oct 27

▼ SELL$54K7,765 shares at $6.96Mark Wilterding Chief Financial OfficerRXST RxSight, Inc.

Watch RXST

Traded: Sep 2, 2026
Disclosed: Sep 2, 2026
Filed: The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

RXSTSimilar stocks (XLV — its sector index fund), rebased to RXST's price on the disclosure day

RXST since disclosure

−30.3%

after the sale

Similar stocks (XLV) since disclosure

+3.6%

XLV — its sector index fund

Change in closing price from Sep 2, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on RXST →